Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

20
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

51
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
51
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

43
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

30
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
30
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

29
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
29
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

32
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
32

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Burst-Learning Electrocardiogram Curriculum for Internal Medicine Residents: A Single-Center Quality Improvement Initiative.

JACC. Case reports·2026
Same author

Pericardial Hemangioma: A Case Report and Updated Literature Review.

JACC. Case reports·2026
Same author

Hospital Safety-Net Burden and Outcomes of COVID-19 Hospitalizations in the US: Analysis of a National Multicenter Database.

Journal of intensive care medicine·2025
Same author

Takotsubo Cardiomyopathy and Internal Carotid Artery Dissection in Rapid Succession.

JACC. Case reports·2025
Same author

Severe Visual-Auditory Impairments and Heart Failure Readmissions: Insights From the National Readmission Database.

JACC. Advances·2025
Same author

Clinical Care Delivery in Chest Pain Patients Without an Acute Coronary Syndrome-A Retrospective Cohort Study.

Journal of clinical medicine·2025

Related Experiment Video

Updated: Sep 5, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

10.5K

Ventricular Noncompaction With Left Ventricular Thrombus: A Case Report.

Anas Alrefaee1, Kyle Wiseman2, Ndausung Udongwo2

  • 1Cardiology, Jersey Shore University Medical Center, Neptune, USA.

Cureus
|July 7, 2022
PubMed
Summary
This summary is machine-generated.

Noncompaction cardiomyopathy (NCC) is a rare congenital heart condition. This case highlights NCC with left ventricular thrombus, prompting anticoagulation in a patient without atrial fibrillation.

Keywords:
cardiomyopathyleft ventricular noncompaction cardiomyopathyleft ventricular thrombusnoncompaction cardiomyopathynoncompaction syndromeventricular trabeculations

More Related Videos

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

12.3K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

425

Related Experiment Videos

Last Updated: Sep 5, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

10.5K
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

12.3K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

425

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Thrombosis

Background:

  • Noncompaction cardiomyopathy (NCC) is a rare congenital cardiomyopathy.
  • It is characterized by left ventricular trabeculations visible on echocardiogram and cardiac magnetic resonance imaging (CMRI).
  • NCC is associated with thromboembolism and an increased risk of ventricular thrombus formation.

Observation:

  • A 73-year-old female presented with a suspected cerebrovascular accident (CVA).
  • Diagnostic imaging (echocardiogram and CMRI) revealed NCC with a left ventricular thrombus.
  • The patient was initiated on warfarin for indefinite anticoagulation.

Findings:

  • This case underscores the rarity of noncompaction cardiomyopathy presenting with left ventricular thrombus.
  • It highlights unique clinical questions regarding anticoagulation strategies (initiation, duration, and agent choice) in NCC patients without atrial fibrillation.

Implications:

  • Consider NCC in patients with unexplained cardioembolic events, such as CVA.
  • Prompt management of NCC with left ventricular thrombus should follow available guidelines, including therapeutic anticoagulation.
  • Further research is needed to establish optimal anticoagulation protocols for NCC-associated thrombosis in the absence of atrial fibrillation.